Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2018-02-02 | PRUDENTIAL FINANCIAL INC | DERMA SCIENCES, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2017-03-10 | BAKER BROS. ADVISORS LP | DERMA SCIENCES, INC. | - | 0.0% | EDGAR |
SC 13D/A | 2017-02-28 | GARDNER LEWIS ASSET MANAGEMENT L P | DERMA SCIENCES, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2017-02-14 | RA CAPITAL MANAGEMENT, LLC | DERMA SCIENCES, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2017-02-08 | FRANKLIN RESOURCES INC | DERMA SCIENCES, INC. | 2,667,600 | 9.4% | EDGAR |
SC 13G/A | 2017-02-02 | JENNISON ASSOCIATES LLC | DERMA SCIENCES, INC. | 1,412,577 | 5.0% | EDGAR |
SC 13G/A | 2017-01-24 | PRUDENTIAL FINANCIAL INC | DERMA SCIENCES, INC. | 1,413,177 | 5.0% | EDGAR |
SC 13D | 2017-01-23 | GARDNER LEWIS ASSET MANAGEMENT L P | DERMA SCIENCES, INC. | 2,171,945 | 7.7% | EDGAR |
SC 13D/A | 2017-01-13 | Broadfin Capital, LLC | DERMA SCIENCES, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2016-02-16 | BAKER BROS. ADVISORS LP | DERMA SCIENCES, INC. | 3,752,390 | 14.5% | EDGAR |
SC 13G/A | 2016-02-16 | Flynn James E | DERMA SCIENCES, INC. | 303,030 | 1.2% | EDGAR |
SC 13G/A | 2016-02-11 | Consonance Capital Management LP | DERMA SCIENCES, INC. | 884,402 | 3.4% | EDGAR |
SC 13G/A | 2016-02-10 | PRUDENTIAL FINANCIAL INC | DERMA SCIENCES, INC. | 1,801,306 | 7.0% | EDGAR |
SC 13G/A | 2016-02-05 | JENNISON ASSOCIATES LLC | DERMA SCIENCES, INC. | 1,800,006 | 6.9% | EDGAR |
SC 13G | 2016-01-29 | RA CAPITAL MANAGEMENT, LLC | DERMA SCIENCES, INC. | 2,055,676 | 8.0% | EDGAR |
SC 13G | 2016-01-08 | FRANKLIN RESOURCES INC | DERMA SCIENCES, INC. | 2,619,308 | 10.2% | EDGAR |
SC 13D/A | 2015-12-16 | Broadfin Capital, LLC | DERMA SCIENCES, INC. | 2,562,104 | 9.9% | EDGAR |
SC 13G/A | 2015-12-10 | FMR LLC | DERMA SCIENCES, INC. | 0 | 0.0% | EDGAR |
SC 13G | 2015-04-16 | Flynn James E | DERMA SCIENCES, INC. | 1,382,970 | 5.3% | EDGAR |
SC 13D/A | 2015-03-20 | Broadfin Capital, LLC | DERMA SCIENCES, INC. | 2,130,477 | 8.3% | EDGAR |